iShares US Healthcare Providers ETF

IHF

Market cap $1.19B

Launched on May 1, 2006, the iShares U.S. Healthcare Providers ETF (IHF) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Healthcare - Providers segment of the equity market.

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Looking for broad exposure to the Healthcare - Healthcare - Providers segment of the equity market? You should consider the iShares U.S. Healthcare Providers ETF (IHF), a passively managed exchange traded fund launched on May 1, 2006.

Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.

The healthcare sector is undervalued based on historical averages, especially the healthcare equipment and healthcare providers industries. iShares U.S. Healthcare Providers ETF (IHF) offers capital-weighted exposure to healthcare providers with significant company-specific risk. IHF is best suited for tactical allocation, not long-term holding, due to deep drawdowns, high volatility and long-term underperformance.

Iran tensions rattle markets, but select sector ETFs stay resilient. Here are 5 funds gaining momentum amid volatility.

Launched on May 1, 2006, the iShares U.S. Healthcare Providers ETF (IHF) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Healthcare - Providers segment of the equity market.

Over the past three years, healthcare has been among the worst-performing sectors. 2026's market rotation away from tech is bringing new life to more defensive areas of the market.

The iShares U.S. Healthcare Providers ETF (IHF) was launched on May 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Healthcare - Providers segment of the equity market.

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.